Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1α and mitochondrial respiration
Authors:
Open Access
- 1 January 2012
- journal article
- Published by Wiley in FEBS Open Bio
- Vol. 2 (1) , 113-118
Abstract
We examined carbon monoxide (CO) delivery by carbon monoxide‐releasing molecule 2 (CORM‐2) or hemoglobin (Hb) on cellular oxygen sensing and mitochondrial respiration in bovine aortic endothelial cells (BAECs). CORM‐2 reduced hypoxia‐inducible factor‐1α (HIF‐1α) and endothelin‐1 (ET‐1) expression in normoxic and hypoxic cells, but while Hb alone significantly reduced HIF‐1α stabilization in hypoxic cells, CO delivered by Hb (Hb‐CO) had no effect on HIF‐1α stabilization. CO dose‐dependently increased basal oxygen consumption and reduced overall mitochondrial respiratory capacity. Hb‐CO increased basal oxygen consumption but did not alter respiratory capacity. Together, CO reduced ET‐1, and, at low doses, had no effect on endothelial mitochondria oxygen consumption. CO ligation to Hb may be developed further as non‐vasoactive oxygen therapeutic without compromising mitochondrial function.Keywords
This publication has 26 references indexed in Scilit:
- Carbon Monoxide Promotes Respiratory Hemoproteins Iron Reduction Using Peroxides as Electron DonorsPLOS ONE, 2012
- Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2011
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- The therapeutic potential of carbon monoxideNature Reviews Drug Discovery, 2010
- Early Treatment of Transient Focal Cerebral Ischemia with Bovine PEGylated Carboxy Hemoglobin TransfusionArtificial Cells, Blood Substitutes, and Biotechnology, 2010
- Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen speciesFree Radical Biology and Medicine, 2010
- CO‐MP4, a polyethylene glycol‐conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in ratsBritish Journal of Pharmacology, 2008
- Use of carbon monoxide as a therapeutic agent: promises and challengesIntensive Care Medicine, 2008
- Carbon Monoxide-Releasing MoleculesCirculation Research, 2002
- Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide.Journal of Clinical Investigation, 1995